Holen Sie sich die Stockscreener-App
57.45
1.47%
0.945
Schlusskurs vom Vortag:
$56.50
Offen:
$56.27
24-Stunden-Volumen:
1.18M
Relative Volume:
0.44
Marktkapitalisierung:
$12.97B
Einnahmen:
$4.03B
Nettoeinkommen (Verlust:
$789.50M
KGV:
17.25
EPS:
3.33
Netto-Cashflow:
$1.15B
1W Leistung:
+0.30%
1M Leistung:
-7.26%
6M Leistung:
-28.76%
1J Leistung:
-23.48%
1-Tages-Spanne:
$55.89
$57.45
1-Wochen-Bereich:
$55.89
$59.02
52-Wochen-Spanne:
$55.89
$84.67
Hologic Inc Stock (HOLX) Company Profile
Firmenname
Hologic Inc
Sektor
Telefon
(508) 263-2900
Adresse
250 CAMPUS DRIVE, MARLBOROUGH, MA
Vergleichen Sie HOLX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HOLX
Hologic Inc
|
57.41 | 12.97B | 4.03B | 789.50M | 1.15B | 3.33 |
|
ISRG
Intuitive Surgical Inc
|
486.81 | 173.82B | 8.35B | 2.32B | 1.30B | 6.41 |
|
BDX
Becton Dickinson Co
|
200.53 | 57.28B | 20.64B | 1.73B | 2.94B | 6.02 |
|
ALC
Alcon Inc
|
92.35 | 45.42B | 9.91B | 1.02B | 665.00M | 2.05 |
|
RMD
Resmed Inc
|
213.78 | 31.24B | 4.93B | 1.25B | 1.38B | 8.47 |
|
COO
The Cooper Companies, Inc.
|
79.28 | 15.78B | 3.90B | 392.30M | 288.10M | 1.95 |
Hologic Inc Stock (HOLX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-03 | Herabstufung | Argus | Buy → Hold |
| 2025-02-06 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2025-02-03 | Herabstufung | Needham | Buy → Hold |
| 2024-12-13 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-12-10 | Eingeleitet | Jefferies | Hold |
| 2024-12-10 | Bestätigt | Needham | Buy |
| 2024-10-01 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-06-27 | Eingeleitet | Stephens | Overweight |
| 2024-04-03 | Hochstufung | Citigroup | Neutral → Buy |
| 2023-07-14 | Hochstufung | Needham | Hold → Buy |
| 2022-12-07 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2022-10-13 | Eingeleitet | Mizuho | Buy |
| 2022-07-20 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-07-20 | Eingeleitet | UBS | Neutral |
| 2022-07-18 | Herabstufung | BTIG Research | Buy → Neutral |
| 2022-04-25 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-04-04 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2021-12-15 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-10-14 | Eingeleitet | Redburn | Neutral |
| 2021-07-06 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2020-11-20 | Herabstufung | Needham | Buy → Hold |
| 2020-11-05 | Bestätigt | Needham | Buy |
| 2020-06-30 | Hochstufung | Cowen | Market Perform → Outperform |
| 2020-06-03 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2020-04-30 | Bestätigt | Needham | Buy |
| 2020-04-30 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2020-04-07 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2020-03-27 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2020-01-13 | Bestätigt | Needham | Buy |
| 2020-01-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2020-01-02 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2019-09-26 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-08-01 | Bestätigt | Needham | Buy |
| 2019-05-02 | Bestätigt | Needham | Buy |
| 2019-01-31 | Bestätigt | Needham | Buy |
| 2019-01-02 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2018-10-09 | Eingeleitet | UBS | Neutral |
| 2018-09-13 | Herabstufung | BofA/Merrill | Buy → Neutral |
Alle ansehen
Hologic Inc Aktie (HOLX) Neueste Nachrichten
Virology Testing Market Detailed In New Research Report 2025 | - openPR.com
Hyperpigmentation Treatment Devices Market Projected - openPR.com
Breast Lesion Localization Methods Market Detailed In New - openPR.com
Biopsy Devices Market Set to Witness Significant Growth - openPR.com
Mizuho Securities Cuts Hologic Price Target to $75 From $83, Maintains Outperform Rating - MarketScreener
Sentinel Node Biopsy Market Growth in 2025 Driven by Precision - openPR.com
Sentinel Node Biopsy Market to Witness Remarkable Growth with - openPR.com
BofA Reduces Price Target for Hologic (HOLX) Amid Industry Headw - GuruFocus
Why Hologic (HOLX) Outpaced the Stock Market Today - Yahoo Finance
What Does Hologic, Inc.'s (NASDAQ:HOLX) Share Price Indicate? - Yahoo Finance
Fluoroscopy Devices Market Is Booming Worldwide with Positive - openPR.com
Breast Cancer Brachytherapy Market Future Business - openPR.com
Immunoassay Analyzers Market Size to Hit USD 10.16 Billion by 2032 | SNS Insider - GlobeNewswire Inc.
Hologic, Inc. (HOLX) is Attracting Investor Attention: Here is What You Should Know - MSN
X-ray Machine Manufacturing Market Generated Opportunities, - openPR.com
Hologic stock hits 52-week low at $57.36 amid market shifts - Investing.com India
Hologic stock hits 52-week low at $57.36 amid market shifts By Investing.com - Investing.com South Africa
Non-Invasive Cancer Diagnostics Market to Witness Massive - openPR.com
Q4 Earnings Outperformers: Hologic (NASDAQ:HOLX) And The Rest Of The Medical Devices & SuppliesImaging, Diagnostics Stocks - Yahoo Finance
Analyzing Hologic, Inc. v. Stepp: Key takeaways - Eversheds Sutherland
Histology And Cytology Market Is Booming Worldwide 2025-2032 | - openPR.com
Digital X-ray Devices Market to Witness Massive Growth by 2032 | - openPR.com
Virology Testing Market to Witness Remarkable Growth with - openPR.com
RBC Cuts Price Target on Hologic to $75 From $83, Keeps Sector Perform Rating - MarketScreener
Hologic (HOLX) Advances While Market Declines: Some Information for Investors - Yahoo Finance
Hologic adds Solventum CFO McMillan to its board - MassDevice
Hologic Brings In New Leadership: A Signal To Stay Put With The Stock? - Barchart.com
Hologic Brings in New Leadership: A Signal to Stay Put With the Stock? - Yahoo Finance
Hologic Onboards Wayde McMillan to its Board of Directors - World Business Outlook
Wayde McMillan Elected to Hologic Board of Directors - citybiz
Hologic adds Wayde McMillan to its Board of Directors By Investing.com - Investing.com South Africa
Hologic Expands Board with New Director Appointment - TipRanks
Hologic adds Wayde McMillan to its Board of Directors - Investing.com
Wayde Mcmillan Elected To Hologic Board Of Directors - MarketScreener
Wayde McMillan Elected to Hologic Board of Directors – Company Announcement - Financial Times
Hologic to Announce Financial Results for the Second Quarter of Fiscal 2025 on Thursday, May 1, 2025 - MarketScreener
Biopsy Devices Market Projected To Witness Massive Growth, - openPR.com
Groupama Asset Managment Acquires 21,037 Shares of Hologic, Inc. (NASDAQ:HOLX) - MarketBeat
Mark Your Calendar: Hologic Sets Critical Q2 Earnings Report Date - Stock Titan
Evercore ISI Adjusts Price Target on Hologic to $65 From $73, Maintains In Line Rating - MarketScreener
Mitsubishi UFJ Trust & Banking Corp Has $13.99 Million Stock Position in Hologic, Inc. (NASDAQ:HOLX) - MarketBeat
RBC Adjusts Price Target on Hologic to $83 From $85, Maintains Sector Perform Rating - MarketScreener
Finanzdaten der Hologic Inc-Aktie (HOLX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Hologic Inc-Aktie (HOLX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Mitchell Essex D | Chief Operating Officer |
Dec 04 '24 |
Sale |
76.34 |
24,856 |
1,897,482 |
27,957 |
0.27%
0.61%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):